HDV - iShares Core High Dividend ETF

NYSE American - NYSE American Delayed Price. Currency in USD
85.74
-0.16 (-0.19%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close85.90
Open85.65
Bid0.00 x 0
Ask0.00 x 0
Day's Range85.59 - 85.83
52 Week Range82.16 - 94.20
Volume177,337
Avg. Volume323,039
Net Assets5.7B
NAV84.96
PE Ratio (TTM)N/A
Yield3.65%
YTD Return-3.92%
Beta (3y)0.72
Expense Ratio (net)0.08%
Inception Date2011-03-29
Trade prices are not sourced from all markets
  • ETF Trends8 days ago

    Dividend ETFs: Capitalizing on a Trump Bump?

    President Donald Trump enacted a tax reform plan that allowed companies to repatriate billions of dollars in overseas revenue back home, driving increased demand for dividend stock ETF strategies that ...

  • Merck’s Post-1Q18 Valuation
    Market Realist2 months ago

    Merck’s Post-1Q18 Valuation

    In 1Q18, Merck’s revenue grew 6% YoY (year-over-year) to $10.0 billion from $9.4 billion, and its EPS (earning per share) rose to $1.05 from $0.88. In this part, we’ll look at how Merck’s valuation multiples compare.

  • What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?
    Market Realist3 months ago

    What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?

    As discussed earlier, Johnson & Johnson (JNJ) reported revenue growth of 12.6% in its 1Q18 revenues to $20.0 billion.

  • Analysts’ Recommendations for Johnson & Johnson on April 16
    Market Realist3 months ago

    Analysts’ Recommendations for Johnson & Johnson on April 16

    Johnson & Johnson (JNJ) reported revenues of $20.2 billion during 4Q17—11.5% growth compared to 4Q16. Wall Street analysts expect Johnson & Johnson to generate earnings per share of $2.00 on revenues of $19.4 billion in 1Q18—9.2% revenue growth compared to $17.8 billion in 1Q17. The revenue growth is expected to be driven by increased sales across all three business segments.

  • InvestorPlace4 months ago

    3 Top Low-Cost Dividend Funds to Buy

    When it comes to investing in dividend funds, there are a few trade-offs to be aware of. Of course, everyone is looking for low-cost dividend funds, and yet low-cost dividend funds usually mean passively managed exchange-traded funds or mutual funds. Expenses are going to rise as you move into higher-yielding securities that require more active management.

  • Factors that Could Drive Dominion Energy’s Dividend Growth
    Market Realist5 months ago

    Factors that Could Drive Dominion Energy’s Dividend Growth

    What Are the Top S&P 500 Utility Dividend Growers?

  • ETF Trends5 months ago

    A Venerable Dividend ETF for Conservative Investors

    The iShares Core High Dividend ETF (NYSEArca: HDV), which allocates nearly 21% of its weight to consumer staples stocks, could be an ideal dividend exchange traded fund for conservative income investors ...

  • Why The Kraft Heinz Company’s Outlook Still Seems Promising
    Market Realist6 months ago

    Why The Kraft Heinz Company’s Outlook Still Seems Promising

    Last Year's Top 18 S&P 500 Stocks by Dividend Growth

  • 5 ETFs to Bet on 2018 Dogs of the Dow
    InvestorPlace6 months ago

    5 ETFs to Bet on 2018 Dogs of the Dow

    Although the ‘Dogs of the Dow’ strategy has a history of outperforming the Dow Jones Industrial Average over the long term, it lagged in 2017, returning just 19% compared with 25% gains for the blue-chip index. Before 2017, the Dogs had generated outsized returns in six of the seven previous years, missing only in 2012.Source: ©iStock.com/jesse757

  • ETF Trends7 months ago

    A Dependable Dividend ETF For 2018

    The iShares Core High Dividend ETF (NYSEArca: HDV) gained just over 13% last year. While that performance lagged the broader market, HDV remains a solid bet for dividend investors in 2018. HDV follows ...

  • ETF Trends10 months ago

    Nervous Investor? Consider These 3 Dividend ETFs

    Yields remain low and spikes in volatility have caused some concern. Nevertheless, investors may consider a dividend ETF to generate stable returns. Yields on benchmark 10-year Treasury notes have declined ...

  • Market Realist10 months ago

    Decoding Helmerich & Payne’s Dividend Yield

    Contract oil and gas well driller Helmerich & Payne (HP) recorded a sharp drop in its 2016 operating revenue due to declines in its US drilling, offshore, and international segments.…

  • Market Realist11 months ago

    A Post-2Q17 Update on Pfizer’s Oncology Drugs: Sutent, Xalkori, and Inlyta

    In 2Q17, Inlyta generated revenues of ~$88 million, which represents an ~19% decline on a YoY basis and ~4% growth on a quarter-over-quarter basis.

  • ETF Trends11 months ago

    Dividend ETFs Can Shine Again After Trailing Market

    Among the dividend-oriented exchange traded funds that trailing the broader market this year, there is the iShares Core High Dividend ETF (NYSEArca: HDV). HDV is up just 3.6% year-to-date, but this ETF ...

  • Market Realist11 months ago

    Dividend Yield of Procter & Gamble

    Procter & Gamble’s (PG) PE ratio of 25.1x compares to a sector average of 23.3x. The dividend yield of 3.0% compares to a sector average of 3.8%.

  • 5 Cheap Dividend ETFs for an Uncertain Market
    Zacks11 months ago

    5 Cheap Dividend ETFs for an Uncertain Market

    Dividend products offer safety in the form of payouts and stability in the form of mature companies that are less volatile to the large swings in stock prices.

  • Market Realist11 months ago

    Consolidated Edison’s Dividend Trajectory

    Consolidated Edison’s (ED) 2016 operating revenues fell 4.0% due to a decline in every segment; namely, electric, gas, steam, and non-utility.

  • Market Realist11 months ago

    Pfizer’s Corporate and Pipeline Developments in 2Q17

    Apart from Pfizer’s (PFE) product developments, let's take a look at some recent pipeline and corporate developments.

  • Benzingalast year

    Revisiting Some High Dividend ETFs

    With higher beta — cyclical sectors leading U.S. equities higher — it is not surprising that some conservatively-positioned high dividend strategies are not keeping pace with the S&P 500. That combined ...

  • Market Realistlast year

    Pfizer Sees a Significant Opportunity in This for Revenue Growth

    In 2016, Pfizer’s (PFE) biosimilar business reported revenues of ~$319 million, compared with $63 million in 2015.

  • 3 Dividend ETFs to Keep You Invested After Retirement
    Motley Foollast year

    3 Dividend ETFs to Keep You Invested After Retirement

    These funds can form the bedrock of a retiree's income-generation portfolio.